Inclusion bodies (IBs) are dense aggregates of misfolded recombinant protein that accumulate in the cytoplasm of E. coli during high-level expression. They form when the rate of protein synthesis exceeds the cell's folding capacity, especially for proteins with complex disulfide bonds, large molecular weight, or hydrophobic domains. While IBs are often considered a disadvantage, they offer benefits: high expression levels (30-50% of total cell protein), easy initial purification by centrifugation, and protection from proteolysis.
Both urea and guanidine hydrochloride (GdnHCl) are chaotropic agents that denature and solubilize inclusion bodies. GdnHCl is a stronger denaturant: 6M GdnHCl is roughly equivalent to 8M urea in denaturing power. GdnHCl is preferred for complex proteins with multiple disulfide bonds because it provides more complete unfolding. Urea is cheaper and non-ionic (compatible with ion exchange chromatography), but can cause carbamylation of amino groups at elevated temperatures. GdnHCl is ionic and must be removed before ion exchange or hydrophobic interaction steps.
L-arginine (0.4-0.8M) is the most widely used refolding additive because it suppresses protein aggregation without significantly stabilizing the unfolded state. It acts as a "chemical chaperone" by binding to partially folded intermediates and increasing their solubility. Unlike detergents, arginine does not interfere with downstream chromatography. The mechanism involves interactions with aromatic and hydrophobic residues that would otherwise drive aggregation. Arginine is effective for a wide range of proteins and is often the single most impactful additive.
The reduced glutathione (GSH) and oxidized glutathione (GSSG) redox pair provides a controlled oxidizing environment for disulfide bond formation during refolding. GSSG oxidizes free cysteines to form disulfides, while GSH allows reshuffling of incorrect disulfide bonds. The GSH:GSSG ratio (typically 5:1 to 10:1) determines the redox potential of the buffer. Higher GSSG concentrations drive oxidation, while GSH maintains enough reducing power for disulfide isomerization. The optimal ratio depends on the number of disulfide bonds and the protein's native redox environment.
The choice depends on protein properties and scale. Rapid dilution (1:20-1:100) is simplest but requires large buffer volumes. Stepwise dialysis is gentler and better for complex proteins with multiple disulfide bonds. On-column refolding (using Ni-NTA for His-tagged proteins) keeps protein concentrated and immobilized, preventing aggregation. Pulse refolding (sequential additions of denatured protein to refolding buffer) achieves higher final concentrations. For initial screening, try rapid dilution first. For production, on-column or pulse refolding are preferred for efficiency.
Lower protein concentrations during refolding generally improve yield by reducing aggregation, which is a concentration-dependent process. Typical targets are 0.01-0.1 mg/mL for dilution refolding. Simple proteins without disulfide bonds can tolerate higher concentrations (0.1-0.5 mg/mL). Complex proteins with multiple disulfides may need concentrations as low as 0.01-0.02 mg/mL. On-column refolding circumvents this limitation because proteins are immobilized and cannot aggregate intermolecularly. The trade-off is always between yield per batch and final volume.